← Open Payments lookup

A. FRANCES ADAMS: Open Payments

NPI 1710610167 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$403 in 17 payments from 7 companies in 2025. Trend: 2023 $1,645 · 2024 $2,040 · 2025 $403

Food & beverage: $403
CompanyPaymentsAmount
GENZYME CORPORATION5$135
Takeda Pharmaceuticals U.S.A., Inc.3$66
ABBVIE INC.3$66
PFIZER INC.2$44
Janssen Biotech, Inc.2$38
Gilead Sciences, Inc.1$28
Ardelyx, Inc.1$27

Products named: DUPIXENT, RINVOQ, XELJANZ, ENTYVIO, TREMFYA, IBSRELA, GATTEX, LINZESS.

Industry payments across VA — which companies pay providers there.